Celgene To Snap Up Gloucester Pharma For $640M
Biopharmaceutical giant Celgene Corp. revealed plans Monday to acquire privately held Gloucester Pharmaceuticals Inc. in a deal valued at up to $640 million, a move designed to boost Celgene's ability to...To view the full article, register now.
Already a subscriber? Click here to view full article